capecitabine has been researched along with Body-Weight Trajectory in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorresteijn, B; Jourdan, M; Koopman, M; Kurk, SA; May, AM; Oskam, MJ; Peeters, PHM; Punt, CJA; Stellato, RK | 1 |
1 trial(s) available for capecitabine and Body-Weight Trajectory
| Article | Year |
|---|---|
Trajectory of body mass and skeletal muscle indices and disease progression in metastatic colorectal cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Body-Weight Trajectory; Capecitabine; Colorectal Neoplasms; Disease Progression; Female; Humans; Male; Middle Aged; Muscle, Skeletal; Neoplasm Metastasis; Palliative Care | 2019 |